← Eichor
Study identifier: NCT06487585 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

ANG-First Trial (Angiotensin II as First-Line Vasopressor Therapy in Cardiac Surgery)

Condition: Vasodilatory Hypotension During or After Cardiac Surgery  ·  Sponsor: University of Maryland St. Joseph Medical Center

PhasePhase 4
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The purpose of this research is to evaluate the use of Angiotensin II in patients with low blood pressure post-surgery. Your information will be collected for 28 days post the procedure and initiation of the study drug to assess for safety events and complications.

This description comes directly from the study's public registry record.

Talk to the study team

Aja Janyavula  ·  410-427-5459  ·  ajanyavula@umm.edu

Sam Rudow  ·  410-427-5459  ·  samuel.rudow@umm.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of Maryland St. Joseph Medical CenterTowson, Maryland, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06487585